[et_pb_section fb_built=\u00bb1″ admin_label=\u00bbHeader\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bb35f37621-1062-4ae6-955d-76a3167a2aa8″ background_image=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2024\/12\/pexels-pixabay-267582.jpg\u00bb parallax=\u00bbon\u00bb min_height=\u00bb280.8px\u00bb min_height_tablet=\u00bb367px\u00bb min_height_phone=\u00bb262.4px\u00bb min_height_last_edited=\u00bbon|phone\u00bb height=\u00bb289px\u00bb height_tablet=\u00bb289px\u00bb height_phone=\u00bb159px\u00bb height_last_edited=\u00bbon|phone\u00bb custom_margin_tablet=\u00bb\u00bb custom_margin_phone=\u00bb-17px||||false|false\u00bb custom_margin_last_edited=\u00bbon|phone\u00bb custom_padding=\u00bb0vw||0vw||true|false\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22background_color_gradient_stops%22%93}\u00bb][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#FFFFFF\u00bb header_2_text_color=\u00bb#FFFFFF\u00bb custom_padding=\u00bb1px|||||\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n
[\/et_pb_text][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#FFFFFF\u00bb custom_margin=\u00bb-22px|||||\u00bb custom_margin_tablet=\u00bb-22px|||||\u00bb custom_margin_phone=\u00bb-35px||||false|false\u00bb custom_margin_last_edited=\u00bbon|phone\u00bb text_font_size_tablet=\u00bb\u00bb text_font_size_phone=\u00bb13px\u00bb text_font_size_last_edited=\u00bbon|phone\u00bb text_line_height_tablet=\u00bb\u00bb text_line_height_phone=\u00bb1.4em\u00bb text_line_height_last_edited=\u00bbon|phone\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n
Los editoriales de R3i, creados por miembros de la junta de R3i, se centran en abordar los retos persistentes del riesgo cardiovascular residual. Estos editoriales sirven para educar a los profesionales sanitarios sobre los nuevos conocimientos y estrategias terap\u00e9uticas relacionados con los factores de riesgo lip\u00eddicos, como las lipoprote\u00ednas ricas en triglic\u00e9ridos y la lipoprote\u00edna(a). <\/span><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ _builder_version=\u00bb4.27.3″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb-49px|||||\u00bb custom_padding=\u00bb2px||40px|||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_2_text_color=\u00bbgcid-primary-color\u00bb custom_margin=\u00bb||-13px|||\u00bb custom_padding=\u00bb9px|||27px|false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22header_2_text_color%22%93}\u00bb]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_2,1_2″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb border_radii=\u00bboff|13px|13px|13px|13px\u00bb border_width_all=\u00bb4px\u00bb border_color_all=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb border_width_all_tablet=\u00bb4px\u00bb border_width_all_phone=\u00bb0px\u00bb border_width_all_last_edited=\u00bbon|phone\u00bb border_color_all_tablet=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb border_color_all_phone=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb border_color_all_last_edited=\u00bbon|phone\u00bb box_shadow_style=\u00bbpreset2″ global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22border_color_all%22%93}\u00bb][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb text_font_size=\u00bb14px\u00bb header_5_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb inline_fonts=\u00bbAbyssinica SIL\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_5_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n Descripta por primera vez hace 60 a\u00f1os, la lipoprote\u00edna(a) [Lp(a)] es reconocida actualmente como un factor que contribuye en gran medida al riesgo cardiovascular residual. Hay numerosos datos que demuestran que la concentraci\u00f3n de Lp(a) se asocia de manera continua con el riesgo cardiovascular, independientemente del colesterol de lipoprote\u00ednas de baja densidad (C-LDL) (1,2). La reducci\u00f3n del C-LDL no aten\u00faa este riesgo (2). La Lp(a) elevada tambi\u00e9n es prevalente en la enfermedad cardiovascular ateroscler\u00f3tica, y afecta aproximadamente a una de cada cinco personas con esta enfermedad (3,4). En conjunto, estos hallazgos ponen de manifiesto la necesidad de ampliar las pruebas de determinaci\u00f3n de Lp(a) para detectar a los pacientes en riesgo, en consonancia con las gu\u00edas de pr\u00e1ctica cl\u00ednica, que recomiendan medir la Lp(a) al menos una vez en todos los adultos (5,6). <\/p>\n Si bien los conocimientos actuales cuestionan el concepto de un umbral \u00fanico de Lp(a) en relaci\u00f3n con el riesgo cardiovascular, la pr\u00e1ctica cl\u00ednica requiere criterios pragm\u00e1ticos que orienten el manejo seg\u00fan el riesgo. Aunque no existe una concentraci\u00f3n espec\u00edfica definida para la Lp(a), la Sociedad Europea de Aterosclerosis propone puntos de corte para descartar el riesgo asociado (<30 mg\/dl o<75 nmol\/l) o confirmarlo (>50 mg\/dl o >125 nmol\/l), adem\u00e1s de una zona intermedia (30-50 mg\/dl o 75-125 nmol\/l) en la que debe considerarse el riesgo atribuible a la Lp(a) en presencia de otros factores de riesgo y en cuanto a la estratificaci\u00f3n del riesgo (1). Las gu\u00edas actuales tambi\u00e9n se\u00f1alan que una concentraci\u00f3n de Lp(a) >50 mg\/dl (aproximadamente >125 nmol\/l) se asocia con un aumento del riesgo cardiovascular (5,6). Sin embargo, el uso de un \u00fanico punto de corte puede no ser representativo a nivel mundial, dado que las concentraciones de Lp(a) var\u00edan seg\u00fan el origen \u00e9tnico. En el estudio INTERASPIRE (Acci\u00f3n Internacional en la Prevenci\u00f3n Secundaria mediante la Intervenci\u00f3n para Reducir Complicaciones), que incluy\u00f3 pacientes hospitalizados por cardiopat\u00eda coronaria, la mediana de Lp(a) fue m\u00e1s elevada en \u00c1frica (62 nmol\/l) y m\u00e1s baja en el Pac\u00edfico Occidental (22 nmol\/l) (3). Los resultados del estudio Lp(a)JAPAN, que es el estudio de referencia [EG1] de este mes, respaldan adem\u00e1s la propuesta de bajar los umbrales de riesgo asociados a la Lp(a) en poblaciones con concentraciones m\u00e1s bajas de esta lipoprote\u00edna (7), aspecto que merece ser investigado con mayor profundidad. <\/p>\n No obstante, la sola aplicaci\u00f3n de pruebas diagn\u00f3sticas no aliviar\u00e1 la carga del riesgo cardiovascular asociado a la Lp(a). Los m\u00e9dicos tambi\u00e9n deben tratar de forma m\u00e1s intensiva a los pacientes con concentraciones elevadas de Lp(a). Esto ha resultado dif\u00edcil debido a la ausencia de tratamientos espec\u00edficos dirigidos a reducir la Lp(a). Si bien las intervenciones en el modo de vida son eficaces dentro de una estrategia global de manejo del riesgo cardiovascular, no modifican la concentraci\u00f3n de Lp(a) (1). En cuanto a los tratamientos disponibles, las estatinas no reducen la Lp(a) e, incluso, pueden aumentar sus concentraciones (1). Los inhibidores de PCSK9 han demostrado un beneficio modesto (8,9), aunque el grado de reducci\u00f3n de la Lp(a) puede ser insuficiente en la mayor\u00eda de los pacientes con concentraciones elevadas. <\/p>\n <\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb text_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb text_font_size=\u00bb14px\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22text_text_color%22%93}\u00bb]<\/p>\n Actualmente se est\u00e1n evaluando nuevos tratamientos dirigidos espec\u00edficamente a la Lp(a) en importantes estudios de resultados cardiovasculares (10-12). Siempre que se demuestre que la reducci\u00f3n de la Lp(a) reduce significativamente la incidencia de eventos cardiovasculares, estos tratamientos modificar\u00e1n el abordaje cl\u00ednico del riesgo cardiovascular residual asociado a la Lp(a). Sin embargo, como ocurri\u00f3 con los inhibidores de PCSK9, es probable que existan obst\u00e1culos para su incorporaci\u00f3n a la pr\u00e1ctica cl\u00ednica. El costo ser\u00e1 un factor limitante importante, y es probable que se restringa su uso a pacientes con concentraciones muy elevadas de Lp(a), en consonancia con los criterios de inclusi\u00f3n de los estudios de resultados. Estos ensayos establecieron criterios de inclusi\u00f3n muy estrictos, con concentraciones que oscilaron entre >70 mg\/dl (aproximadamente>175 nmol\/l) para el oligonucle\u00f3tido antisentido pelacarsen (10), y hasta 200 nmol\/l para los tratamientos con ARN peque\u00f1o de interferencia (siRNA) lepodisiran y olpasiran (11,12). Sin embargo, los datos del estudio INTERASPIRE muestran que aproximadamente el 50% de los pacientes presentan concentraciones elevadas de Lp(a) que est\u00e1n por debajo de esos valores y que, por lo tanto, no cumplir\u00edan los criterios para ser incluidos en los ensayos (3). Lo mismo ocurre en poblaciones con concentraciones m\u00e1s bajas de Lp(a); en el estudio Lp(a)JAPAN, aproximadamente el 50% de los pacientes con Lp(a) elevada, incluidos aquellos con C-LDL bien controlado, presentaban concentraciones \u226530 y<50 mg\/dl (\u226575 y <125 nmol\/l) (7). En consecuencia, existe un n\u00famero considerable de pacientes con elevaciones moderadas de Lp(a) que no podr\u00edan acceder a estos tratamientos espec\u00edficos. Para estos pacientes, nuevos datos procedentes de un an\u00e1lisis combinado de ensayos cl\u00ednicos (13), comentado en el informe de Enfoque [EG1] de este mes, sugieren que el inhibidor de la prote\u00edna transportadora de \u00e9steres de colesterol obicetrapib podr\u00eda constituir una alternativa terap\u00e9utica, con el beneficio adicional de reducir eficazmente el C-LDL y la apolipoprote\u00edna B (apoB), adem\u00e1s de ofrecer la ventaja pr\u00e1ctica de su administraci\u00f3n por v\u00eda oral. De cara al futuro, la muvalaplina, una peque\u00f1a mol\u00e9cula de administraci\u00f3n oral que inhibe la uni\u00f3n de la apo(a) y la apoB en el hepatocito e interfiere en el ensamblaje de la Lp(a), podr\u00eda representar otra opci\u00f3n terap\u00e9utica, dada su eficacia para reducir la Lp(a) observada en un ensayo cl\u00ednico inicial (14), aunque todav\u00eda no ha entrado en la fase III de desarrollo cl\u00ednico.<\/p>\n [EG1]I suggest adding URL to Focus report (in Spanish) <\/p>\n En \u00faltima instancia, ser\u00e1 necesario esperar los resultados de los grandes estudios de resultados actualmente en curso con tratamientos espec\u00edficos para reducir la Lp(a) para definir con mayor precisi\u00f3n la estrategia \u00f3ptima para el manejo de las concentraciones elevadas de Lp(a) y reducir el riesgo cardiovascular residual.<\/p>\n [\/et_pb_text][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb text_font_size=\u00bb8px\u00bb hover_enabled=\u00bb0″ global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0″]<\/p>\n Referencias<\/b><\/p>\n Key words: Lipoprotein(a); testing; residual cardiovascular risk; specific Lp(a)-lowering therapy; pelacarsen; olpasiran; lepodisiran; obicetrapib; PCSK9 inhibitor<\/em><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb34px|||||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#000000″ header_2_text_color=\u00bb#000000″ custom_margin=\u00bb||-13px|||\u00bb custom_padding=\u00bb9px|||27px|false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22%93}\u00bb]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb text_font_size=\u00bb15px\u00bb header_2_text_color=\u00bbgcid-primary-color\u00bb header_2_font_size=\u00bb32px\u00bb custom_margin=\u00bb||-13px|||\u00bb custom_padding=\u00bb9px|||27px|false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22header_2_text_color%22%93}\u00bb]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb||20px||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n Los datos m\u00e1s recientes del Atlas de Cardiolog\u00eda de la Sociedad Europea de Cardiolog\u00eda (ESC) (1) reafirman que la enfermedad cardiovascular constituye uno de los principales problemas sanitarios del siglo XXI…<\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1Nzk4MiIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb hover_enabled=\u00bb0″ global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb sticky_enabled=\u00bb0″][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb||20px||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n Este mes ha tra\u00eddo consigo la tan esperada publicaci\u00f3n de los lineamientos estadounidenses actualizados sobre el manejo de la dislipidemia del American College of Cardiology \/ American Heart Association Joint Committee…<\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1NzgwOCIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb||20px||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n Durante d\u00e9cadas, los datos provenientes de estudios poblacionales vincularon los valores m\u00e1s altos de triglic\u00e9ridos (indicativos de mayores concentraciones de lipoprote\u00ednas ricas en triglic\u00e9ridos y colesterol remanente) con un mayor riesgo cardiovascular (1)…<\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1NzcxMCIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb text_font_size=\u00bb15px\u00bb header_2_text_color=\u00bbgcid-primary-color\u00bb header_2_font_size=\u00bb32px\u00bb custom_margin=\u00bb||-13px|||\u00bb custom_padding=\u00bb9px|||27px|false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22header_2_text_color%22%93}\u00bb]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb||20px||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n A pesar de los avances en las estrategias intervencionistas y los tratamientos farmacol\u00f3gicos, el riesgo cardiovascular residual sigue siendo un importante desaf\u00edo cl\u00ednico… <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1NzU4OSIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb||20px||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n \u00bfQu\u00e9 aprendimos sobre el riesgo cardiovascular residual en el a\u00f1o 2025? Lo m\u00e1s trascendental es que nuestro conocimiento del riesgo residual relacionado con los l\u00edpidos sigue ampli\u00e1ndose. <\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1NzExMiIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb||20px||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n Las sesiones cient\u00edficas de la American Heart Association (AHA) 2025 no defraudaron y presentaron datos nuevos e interesantes en el campo de los l\u00edpidos. Una de las estrellas fue el estudio VESALIUS-CV con el\u2026 <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1Njc1OCIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb||20px||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n La identificaci\u00f3n de la lipoprote\u00edna(a) [Lp(a)] como factor de riesgo cardiovascular residual est\u00e1 ganando impulso. Ya existen evidencias claras que respaldan la causalidad de los niveles elevados de Lp(a) en el aumento del riesgo de enfermedad ateroscler\u00f3tica… <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1NjUzOCIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb||20px||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n La inclusi\u00f3n en los ensayos cl\u00ednicos es esencial, dado que los estudios aleatorizados representan la base principal de datos probatorios que dan forma a los lineamientos y a la pr\u00e1ctica cl\u00ednica. No obstante, los estudios de\u2026 <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1NjEyMCIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb||20px||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n Guidelines are not static but evolve as evidence dictates. Thus, it is not surprising that updated guidance to the 2019 European Society of Cardiology\/European Atherosclerosis Society (ESC\/EAS) guidelines has been recently published (1,2). This update has been… <\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1NjIzMCIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb||20px||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n La enfermedad cardiovascular ateroscler\u00f3tica (ASCVD) es la principal causa de morbilidad y mortalidad en todo el mundo (1). Adem\u00e1s, con la obesidad en aumento, en particular entre las personas m\u00e1s j\u00f3venes (2), la ASCVD continuar\u00e1 siendo un problema global.\u2026 <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1NTgxNiIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n Gran cantidad de datos que surgieron de estudios observacionales durante d\u00e9cadas vinculan los triglic\u00e9ridos (TG) plasm\u00e1ticos elevados, un marcador indirecto de las lipoprote\u00ednas ricas en TG y sus remanentes, con un aumento\u2026<\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1NTY1MCIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb text_font_size=\u00bb15px\u00bb header_2_text_color=\u00bbgcid-primary-color\u00bb header_2_font_size=\u00bb32px\u00bb custom_margin=\u00bb||-13px|||\u00bb custom_padding=\u00bb9px|||27px|false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22header_2_text_color%22%93}\u00bb]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n Las complicaciones relacionadas con la diabetes (tanto macrovasculares como microvasculares) tienen un efecto devastador para las personas con diabetes\u2026 <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1NTM1MCIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n En los \u00faltimos tiempos ha resurgido el inter\u00e9s por los triglic\u00e9ridos (TG), un sustituto de las lipoprote\u00ednas aterog\u00e9nicas ricas en TG que ahora se considera que contribuyen al riesgo cardiovascular residual….<\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MjA2NSIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n La enfermedad arterial perif\u00e9rica (EAP) es un reto cada vez mayor. Las estimaciones globales sugieren que >200 millones de individuos en todo el mundo viven con EAP, con m\u00e1s del 40% de esta carga en pa\u00edses de ingresos bajos y medios (1,2)…. <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MjA2MCIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n A pesar de un control \u00f3ptimo de los factores de riesgo, el riesgo cardiovascular residual sigue siendo un reto persistente para los m\u00e9dicos que tratan a pacientes con o alto riesgo de enfermedad cardiovascular ateroscler\u00f3tica (ECVA). Por ello, la atenci\u00f3n se ha centrado en abordar otros factores de este riesgo…. <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDU2NiIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n Dentro del enfoque lip\u00eddico, se ha realizado un esfuerzo considerable para abordar los l\u00edpidos no-LDL implicados en este riesgo. Tras la decepci\u00f3n con las terapias dirigidas a las HDL, la atenci\u00f3n se volvi\u00f3 a dirigir a los triglic\u00e9ridos elevados (TG, un marcador de las lipoprote\u00ednas ricas en TG y sus restos) como posible diana terap\u00e9utica 4….<\/sup> <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDU3OSIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n Hasta la fecha, el colesterol y la inflamaci\u00f3n son los principales objetivos para controlar el riesgo vascular residual. A esto se a\u00f1aden los importantes hallazgos de los ensayos de resultados cardiovasculares con nuevas terapias reductoras de la glucosa,…. <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDU4NSIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n Las personas con enfermedad cardiovascular ateroscler\u00f3tica siguen corriendo un riesgo elevado de sufrir eventos recurrentes. Parte de este riesgo puede atribuirse a factores pr\u00e1cticos, como la inercia cl\u00ednica o las disparidades entre pa\u00edses en el acceso a terapias hipolipemiantes eficaces, como puso de relieve el estudio DA VINCI a escala de la UE….. <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDU5MSIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb text_font_size=\u00bb15px\u00bb header_2_text_color=\u00bbgcid-primary-color\u00bb header_2_font_size=\u00bb32px\u00bb custom_margin=\u00bb||-13px|||\u00bb custom_padding=\u00bb9px|||27px|false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22header_2_text_color%22%93}\u00bb]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n El colesterol remanente sigue atrayendo la atenci\u00f3n como objetivo para reducir el riesgo cardiovascular residual. Convencionalmente, el colesterol remanente se define como el colesterol contenido en las part\u00edculas de lipoprote\u00ednas remanentes, es decir, las lipoprote\u00ednas de muy baja densidad metabolizadas y… <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDU5OCIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n El ictus es la principal causa de discapacidad en todo el mundo y la segunda causa de muerte. Seg\u00fan los \u00faltimos datos del Estudio sobre la Carga Mundial de Morbilidad, el n\u00famero absoluto de ictus ha aumentado un 70% en las tres \u00faltimas d\u00e9cadas (1990 a 2019),… <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDYwNCIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n El riesgo cardiovascular residual ha pasado de ser un concepto 1<\/sup> a convertirse en un objetivo establecido en la investigaci\u00f3n de las enfermedades cardiovasculares. Estudios recientes, en particular los centrados en los l\u00edpidos, han demostrado que el objetivo de un nivel m\u00e1s bajo de colesterol de lipoprote\u00ednas de baja densidad (LDL-C)… <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDYwOSIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb text_font_size=\u00bb15px\u00bb header_2_text_color=\u00bbgcid-primary-color\u00bb header_2_font_size=\u00bb32px\u00bb custom_margin=\u00bb||-13px|||\u00bb custom_padding=\u00bb9px|||27px|false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22header_2_text_color%22%93}\u00bb]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n Las lipoprote\u00ednas ricas en triglic\u00e9ridos han atra\u00eddo mucha atenci\u00f3n como probable diana terap\u00e9utica para reducir el riesgo cardiovascular residual, con el apoyo de pruebas procedentes de amplios estudios epidemiol\u00f3gicos, gen\u00e9ticos y mecan\u00edsticos 1….<\/sup><\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDYxNCIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n Adem\u00e1s del LDL-C, las directrices recomiendan el colesterol no unido a lipoprote\u00ednas de alta densidad (no HDL-C) y la apolipoprote\u00edna (apo)B como objetivos secundarios clave 4<\/sup>. Estos par\u00e1metros pueden permanecer elevados incluso cuando se alcanza el objetivo de LDL-C… <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDYxOSIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n La enfermedad renal cr\u00f3nica (ERC) se reconoce cada vez m\u00e1s como un problema sanitario mundial. Mientras que se ha producido un descenso general de las tasas de mortalidad y de los a\u00f1os de vida ajustados en funci\u00f3n de la discapacidad debidos a enfermedades no transmisibles, no existen tendencias tan favorables para la ERC 1<\/sup>… <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDYyMyIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n 2021 fue una \u00e9poca apasionante en el campo de los l\u00edpidos, especialmente por el mayor reconocimiento de la importancia de las lipoprote\u00ednas ricas en triglic\u00e9ridos (TG) y sus restos para el riesgo de enfermedad cardiovascular ateroscler\u00f3tica (ECVA)….<\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDYyOCIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb text_font_size=\u00bb15px\u00bb header_2_text_color=\u00bbgcid-primary-color\u00bb header_2_font_size=\u00bb32px\u00bb custom_margin=\u00bb||-13px|||\u00bb custom_padding=\u00bb9px|||27px|false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22header_2_text_color%22%93}\u00bb]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n Durante demasiado tiempo, los triglic\u00e9ridos (TG) han sido los grandes olvidados de la enfermedad cardiovascular ateroscler\u00f3tica (ECVA). Los tiempos est\u00e1n cambiando. Pruebas sustanciales procedentes de encuestas epidemiol\u00f3gicas y estudios de aleatorizaci\u00f3n mendeliana apoyan el papel de las lipoprote\u00ednas ricas en TG y sus restos en la v\u00eda causal de la ASCVD 1,2<\/sup>… <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDYzNCIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n La Iniciativa para la Reducci\u00f3n del Riesgo Residual (R3i) ha liderado el campo destacando la importancia del riesgo vascular residual 1,2<\/sup>. Este riesgo abarca tanto el riesgo residual macrovascular como el microvascular,… <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDYzOSIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n La enfermedad arterial perif\u00e9rica (EAP) es una afecci\u00f3n frecuente, pero a menudo infradiagnosticada e infratratada. Estimaciones recientes indican que la EAP afecta a m\u00e1s de 230 millones de personas en todo el mundo 1<\/sup>,… <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDY0MyIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n A pesar del mejor tratamiento basado en la evidencia, los pacientes con enfermedad cardiovascular ateroscler\u00f3tica tienen un alto riesgo de eventos recurrentes. Aunque el objetivo es la inflamaci\u00f3n (como en CANTOS),… <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDY0NyIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n Desde que se inform\u00f3 de los primeros casos de infecci\u00f3n por SARS-CoV-2 asociada a la enfermedad respiratoria grave COVID-19 en Wuhan (China), el mundo ha estado soportando…<\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDY1MiIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n La conexi\u00f3n entre el coraz\u00f3n y el cerebro est\u00e1 reconocida desde hace mucho tiempo. Los estudios epidemiol\u00f3gicos demuestran que un perfil adverso de factores de riesgo cardiovascular, como la hipercolesterolemia, la hipertensi\u00f3n… <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDY1NyIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n Nos encontramos en medio de una epidemia de enfermedades metab\u00f3licas. El s\u00edndrome metab\u00f3lico, tal como lo define una declaraci\u00f3n conjunta de grupos de expertos 1<\/sup>, afecta ya a cerca de un tercio de la poblaci\u00f3n mundial adulta 2<\/sup>… <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDY2MSIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n Hace tiempo que se considera que los \u00e1cidos grasos omega-3 tienen un papel potencial en la reducci\u00f3n del riesgo cardiovascular residual. Los metaan\u00e1lisis han evaluado esta cuesti\u00f3n; entre los m\u00e1s recientes, la suplementaci\u00f3n con omega-3 redujo significativamente el riesgo… <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDY2NyIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb text_font_size=\u00bb15px\u00bb header_2_text_color=\u00bbgcid-primary-color\u00bb header_2_font_size=\u00bb32px\u00bb custom_margin=\u00bb||-13px|||\u00bb custom_padding=\u00bb9px|||27px|false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22header_2_text_color%22%93}\u00bb]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n Las directrices reconocen desde hace tiempo que los triglic\u00e9ridos (TG) elevados son un marcador de riesgo cardiovascular <\/span>1<\/sup>. Indeed, TG and TG-rich lipoproteins are among the atherogenic lipids and lipoproteins believed<\/span>…<\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDY3NiIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n La enfermedad del h\u00edgado graso no alcoh\u00f3lico (EHGNA) es un reto importante para el siglo XXI. Ya afecta a m\u00e1s del 25% de la poblaci\u00f3n mundial 1<\/sup>, con tasas similares entre los pa\u00edses industrializados y los menos desarrollados 2<\/sup>… <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDY4MCIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n Dado que la estenosis de la v\u00e1lvula a\u00f3rtica es un proceso cr\u00f3nico y multifactorial, iniciado muchos a\u00f1os antes de la aparici\u00f3n de los s\u00edntomas cl\u00ednicos, implica una evoluci\u00f3n similar a la ateroscler\u00f3tica con afectaci\u00f3n de…<\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDY4NSIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n Las directrices de tratamiento dan prioridad al colesterol de lipoprote\u00ednas de baja densidad (LDL-C) como principal objetivo lip\u00eddico de intervenci\u00f3n para prevenir la enfermedad cardiovascular ateroscler\u00f3tica (ECVA).1<\/sup>…<\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDY4OSIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n El inter\u00e9s por los \u00e1cidos grasos omega-3 ha resurgido en los dos \u00faltimos a\u00f1os. Esto ha sido impulsado en gran medida por el hist\u00f3rico estudio REDUCE-IT (Reducci\u00f3n de Eventos Cardiovasculares con… <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDY5NCIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb text_font_size=\u00bb15px\u00bb header_2_text_color=\u00bbgcid-primary-color\u00bb header_2_font_size=\u00bb32px\u00bb custom_margin=\u00bb||-13px|||\u00bb custom_padding=\u00bb9px|||27px|false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22header_2_text_color%22%93}\u00bb]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n El ictus es una de las principales causas de muerte en todo el mundo, s\u00f3lo superada por la cardiopat\u00eda isqu\u00e9mica. Sin embargo, aunque se ha producido un descenso de la mortalidad por ictus en las \u00faltimas tres d\u00e9cadas, la prevalencia del ictus ha aumentado,… <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDY5OCIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n Hace tiempo que se reconoce que la dislipidemia aterog\u00e9nica contribuye al riesgo cardiovascular residual modificable.1<\/sup> Hasta la fecha, sin embargo, no existen pruebas definitivas sobre la mejor manera de…<\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDcwMiIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb text_font_size=\u00bb15px\u00bb header_2_text_color=\u00bbgcid-primary-color\u00bb header_2_font_size=\u00bb32px\u00bb custom_margin=\u00bb||-13px|||\u00bb custom_padding=\u00bb9px|||27px|false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22header_2_text_color%22%93}\u00bb]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n Comprender los principales factores que contribuyen al riesgo cardiovascular residual ha sido un asunto tedioso. Con el fracaso de grandes estudios como AIM-HIGH con niacina, y dal-OUTCOMES y ACCELERATE… <\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDcwNyIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n En 2013, la Iniciativa para la Reducci\u00f3n del Riesgo Residual public\u00f3 una segunda \u00abllamada a la acci\u00f3n\u00bb sobre el riesgo cardiovascular residual, tras el documento inicial de 2008.1,2<\/sup> Cinco a\u00f1os despu\u00e9s, \u00bfestamos m\u00e1s cerca de…<\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDcxMSIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbSigue leyendo\u00bb button_alignment=\u00bbright\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bb9bc3f405-43a0-4056-a483-11952257355c\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_icon=\u00bb$||divi||400″ button_icon_color=\u00bbgcid-primary-color\u00bb button_on_hover=\u00bboff\u00bb custom_margin=\u00bb|44px|||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22button_text_color%22,%22button_icon_color%22%93}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbgcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd\u00bb custom_margin=\u00bb20px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{%22gcid-b673dc17-1b2a-464e-affa-1bf1ab41c0fd%22:%91%22background_color%22%93}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_6_text_color=\u00bbgcid-secondary-color\u00bb custom_margin=\u00bb||-12px|||\u00bb custom_padding=\u00bb|28px||28px|false|false\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22,%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_3_text_color%22%93,%22gcid-secondary-color%22:%91%22header_6_text_color%22%93}\u00bb]<\/p>\n\u00daltimo editorial<\/h2>\n
Septiembre 2026<\/span><\/h5>\n
Lipoprote\u00edna(a) y riesgo cardiovascular residual: \u00bfc\u00f3mo tratar a los pacientes?<\/h5>\n
Prof. Peter Libby<\/a>, <\/span>Prof. Michel Hermans<\/a>, Prof. Pierre Amarenco<\/a>, Prof. Lale Tokg\u00f6zoglu <\/a><\/span> <\/h6>\n
\n
M\u00e1s editoriales<\/h2>\n
2026 <\/span><\/h2>\n
Un llamado de atenci\u00f3n sobre los desaf\u00edos que presenta la enfermedad cardiovascular<\/h3>\n
Prof. Peter Libby, Prof. Michel Hermans, Prof. Pierre Amarenco, Prof. Lale Tokg\u00f6zoglu <\/h6>\n
Los lineamientos europeos y estadounidenses sobre la dislipidemia coinciden<\/h3>\n
Prof. Peter Libby, Prof. Michel Hermans, Prof. Pierre Amarenco, Prof. Lale Tokg\u00f6zoglu <\/h6>\n
Aprendizajes para ensayos futuros de tratamientos para reducir los triglic\u00e9ridos<\/h3>\n
Prof. Peter Libby, Prof. Michel Hermans, Prof. Pierre Amarenco, Prof. Lale Tokg\u00f6zoglu <\/h6>\n
2025 <\/span><\/h2>\n
\u00bfEl futuro es el riesgo residual personalizado?<\/h3>\n
Prof. Peter Libby, Prof. Michel Hermans, Prof. Pierre Amarenco, Prof. Lale Tokg\u00f6zoglu <\/h6>\n
Un repaso de lo m\u00e1s destacado de 2025<\/h3>\n
Prof. Peter Libby, Prof. Michel Hermans, Prof. Pierre Amarenco, Prof. Lale Tokg\u00f6zoglu <\/h6>\n
\u00bfQu\u00e9 hay de nuevo en la investigaci\u00f3n sobre los l\u00edpidos? Apreciaciones de AHA 2025 <\/h3>\n
Prof. Peter Libby, Prof. Michel Hermans, Prof. Pierre Amarenco, Prof. Lale Tokg\u00f6zoglu <\/h6>\n
La lipoprote\u00edna(a) es un factor de riesgo cardiovascular residual: identificarla y manejarla.<\/h3>\n
Prof. Peter Libby, Prof. Michel Hermans, Prof. Pierre Amarenco, Prof. Lale Tokg\u00f6zoglu <\/h6>\n
Es necesario que los ensayos cl\u00ednicos representen a una poblaci\u00f3n m\u00e1s amplia<\/h3>\n
Prof. Peter Libby, Prof. Michel Hermans, Prof. Pierre Amarenco<\/h6>\n
Update to the 2019 ESC\/EAS guidelines clarifies lipid management<\/h3>\n
Prof. Peter Libby, Prof. Michel Hermans, Prof. Pierre Amarenco<\/h6>\n
Nuevos abordajes para la disminuci\u00f3n de triglic\u00e9ridos: \u00bfde regreso al futuro con ANGPTL4?<\/h3>\n
Prof. Peter Libby, Prof. Michel Hermans, Prof. Pierre Amarenco<\/h6>\n
\u00bfDeber\u00eda ser mayor el objetivo para los niveles de triglic\u00e9ridos en los ensayos cl\u00ednicos?<\/h3>\n
Prof. Peter Libby, Prof. Michel Hermans, Prof. Pierre Amarenco<\/h6>\n
2024 <\/span><\/h2>\n
El ensayo PROMINENT sugiere nuevas esperanzas para las complicaciones de las extremidades inferiores relacionadas con la diabetes<\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
Nuevos f\u00e1rmacos para reducir los triglic\u00e9ridos<\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
Es necesario actuar sobre la arteriopat\u00eda perif\u00e9rica: \u00bfalguna pista de PROMINENT?<\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
\u00bfNuevas opciones para el riesgo vascular residual en el horizonte?<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
Reducir el riesgo residual: es mejor reducir el colesterol y la inflamaci\u00f3n<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
La interacci\u00f3n microvascular-macrovascular: \u00bfel pr\u00f3ximo objetivo?<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
Dirigirse al riesgo cardiovascular residual: \u00bfqu\u00e9 hay en proyecto?<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
2023 <\/span><\/h2>\n
Colesterol remanente – Evoluci\u00f3n de las pruebas<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
Llamada a la acci\u00f3n sobre el riesgo residual de ictus<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
Riesgo residual en 2023: \u00bfhacia d\u00f3nde?<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
2022 <\/span><\/h2>\n
Riesgo residual relacionado con los l\u00edpidos: \u00bflecciones de PROMINENT?<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
Riesgo cardiovascular residual: \u00bfes la apolipoprote\u00edna B el marcador preferido?<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
Riesgo vascular residual en la enfermedad renal cr\u00f3nica: nuevas opciones en el horizonte<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
Echando la vista atr\u00e1s a 2021, \u00bfqu\u00e9 fue noticia?<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
2021 <\/span><\/h2>\n
Una nueva gu\u00eda del ACC aborda las necesidades cl\u00ednicas no cubiertas de los pacientes de alto riesgo con hipertrigliceridemia leve a moderada<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
Riesgo vascular residual: \u00bfQu\u00e9 importa?<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
Comprender el fracaso de los injertos venosos: papel de PPARalfa en la patobiolog\u00eda<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
Riesgo cardiovascular residual: \u00bfc\u00f3mo identificarlo?<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
S\u00edndrome metab\u00f3lico y COVID-19<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
Triglic\u00e9ridos elevados: relaci\u00f3n entre ASCVD y demencia<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
\u00bfOfrece SPPARM\u03b1 nuevas oportunidades en el s\u00edndrome metab\u00f3lico y la NAFLD?<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
\u00c1cidos grasos omega-3 para el riesgo cardiovascular residual: m\u00e1s preguntas que respuestas<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
2020 <\/span><\/h2>\n
Dirigirse a los triglic\u00e9ridos: Nuevos agentes ampl\u00edan el campo<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
Por qu\u00e9 son necesarios los enfoques multifarmacol\u00f3gicos en la EHNA: descubrimientos con el pemafibrato<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
Lipoprote\u00ednas remanentes ricas en triglic\u00e9ridos: \u00bfuna nueva diana terap\u00e9utica en la estenosis de la v\u00e1lvula a\u00f3rtica?<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
Reducir los triglic\u00e9ridos o el colesterol de lipoprote\u00ednas de baja densidad: \u00bfqu\u00e9 proporciona mayor beneficio cl\u00ednico?<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
El enigma de los \u00e1cidos grasos omega-3<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
2019 <\/span><\/h2>\n
Centrarse en el ictus: m\u00e1s aportaciones para abordar el riesgo cardiovascular residual<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
Consenso internacional de expertos sobre el modulador selectivo del receptor alfa activado por el proliferador de peroxisomas (SPPARM\u03b1): Nuevas oportunidades para abordar el riesgo cardiovascular residual modificable<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
2018 <\/span><\/h2>\n
Riesgo cardiovascular residual: el metabolismo de los triglic\u00e9ridos y la gen\u00e9tica proporcionan una clave<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n
La brecha cl\u00ednica en la gesti\u00f3n del riesgo cardiovascular residual: \u00bfmarcar\u00e1n la diferencia los nuevos enfoques?<\/span><\/h3>\n
Prof. Jean-Charles Fruchart, Prof. Michel P. Hermans, Prof. Pierre Amarenco<\/span><\/h6>\n